Risk Factors Associated with Mortality among Mechanically Ventilated Patients with Coronavirus Disease 2019 Pneumonia: A Multicenter Cohort Study in Japan (J-RECOVER Study).


Journal

Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241

Informations de publication

Date de publication:
01 Aug 2023
Historique:
medline: 4 8 2023
pubmed: 1 5 2023
entrez: 30 4 2023
Statut: ppublish

Résumé

Objective Mortality analyses of patients with coronavirus disease 2019 (COVID-19) requiring invasive mechanical ventilation in Japan are limited. The present study therefore determined the risk factors for mortality in patients with COVID-19 requiring invasive mechanical ventilation. Methods This retrospective cohort study used the dataset from the Japanese multicenter research of COVID-19 by assembling real-word data (J-RECOVER) study that was conducted between January 1 and September 31, 2020. Independent risk factors associated with in-hospital mortality were evaluated using a multivariate logistic regression analysis. Kaplan-Meier estimates of the survival were calculated for different age groups. A subgroup analysis was performed to assess differences in survival rates according to additional risk factors, including an older age and chronic pulmonary disease. Patients A total of 561 patients were eligible. The median age was 67 (interquartile range: 56-75) years old, 442 (78.8%) were men, and 151 (26.9%) died in the hospital. Results Age, chronic pulmonary disease, and renal disease were significantly associated with in-hospital mortality. Compared with patients 18-54 years old, the adjusted odds ratios of patients 55-64, 65-74, and 75-94 years old were 3.34 (95% CI, 1.34-8.31), 7.07 (95% CI, 3.05-16.40), and 18.43 (95% CI, 7.94-42.78), respectively. Conclusion Age, chronic pulmonary disease, and renal disease were independently associated with mortality in patients with COVID-19 requiring invasive mechanical ventilation, and age was the most decisive indicator of a poor prognosis. Our results may aid in formulating treatment strategies and allocating healthcare resources.

Identifiants

pubmed: 37121748
doi: 10.2169/internalmedicine.1740-23
pmc: PMC10465271
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2187-2194

Références

Lancet. 2004 Jan 10;363(9403):157-63
pubmed: 14726171
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
Ann Intensive Care. 2021 Dec 11;11(1):171
pubmed: 34897587
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
PLoS One. 2021 Jun 4;16(6):e0252760
pubmed: 34086779
Am J Epidemiol. 2011 Mar 15;173(6):676-82
pubmed: 21330339
Int J Infect Dis. 2020 Oct;99:47-56
pubmed: 32721533
J Infect Chemother. 2021 Feb;27(2):291-295
pubmed: 33121864
Am J Respir Crit Care Med. 2020 Jul 1;202(1):1-4
pubmed: 32402207
Am J Respir Crit Care Med. 2021 Jan 1;203(1):54-66
pubmed: 33119402
J Infect Chemother. 2021 Feb;27(2):413-417
pubmed: 33342681
J Anesth. 2021 Apr;35(2):213-221
pubmed: 33484361
Geriatr Gerontol Int. 2017 Jul;17(7):1045-1047
pubmed: 28670849
BMC Geriatr. 2021 May 19;21(1):321
pubmed: 34011269
Clin Exp Med. 2022 Feb;22(1):125-135
pubmed: 33891214
J Intensive Care. 2020 Jun 15;8:40
pubmed: 32549989
Med Care. 2005 Nov;43(11):1130-9
pubmed: 16224307
J Glob Health. 2020 Dec;10(2):020503
pubmed: 33110586
Clin Exp Nephrol. 2022 May;26(5):445-452
pubmed: 35230569
Am J Kidney Dis. 2021 Feb;77(2):190-203.e1
pubmed: 32961244
Clin Infect Dis. 2021 Dec 6;73(11):e3677-e3689
pubmed: 32986793
JAMA. 2020 Apr 28;323(16):1545-1546
pubmed: 32167538
Int J Infect Dis. 2021 Jan;102:282-284
pubmed: 33127502
PLoS One. 2021 Feb 11;16(2):e0246318
pubmed: 33571301
Health Syst Reform. 2023 Dec 31;9(1):2175415
pubmed: 36803509
BMC Infect Dis. 2021 Feb 9;21(1):163
pubmed: 33563218
Anaesthesia. 2021 Sep;76(9):1224-1232
pubmed: 34189735
Lancet Respir Med. 2021 Sep;9(9):989-998
pubmed: 34224674
J Gerontol A Biol Sci Med Sci. 2020 Sep 16;75(9):1788-1795
pubmed: 32279081

Auteurs

Mayu Hikone (M)

Tertiary Emergency Medical Center, Tokyo Metropolitan Bokutoh Hospital, Japan.

Keita Shibahashi (K)

Tertiary Emergency Medical Center, Tokyo Metropolitan Bokutoh Hospital, Japan.

Masahiro Fukuda (M)

Senri Critical Care Medical Center, Saiseikai Senri Hospital, Japan.

Yuichiro Shimoyama (Y)

Department of Anesthesiology, Intensive Care Unit, Osaka Medical and Pharmaceutical University, Japan.

Kazuma Yamakawa (K)

Department of Emergency and Critical Care Medicine, Osaka Medical and Pharmaceutical University, Japan.

Akira Endo (A)

Trauma and Acute Critical Care Center, Tokyo Medical and Dental University Hospital, Japan.

Mineji Hayakawa (M)

Department of Emergency Medicine, Hokkaido University Hospital, Japan.

Takayuki Ogura (T)

Department of Emergency Medicine and Critical Care Medicine, Tochigi Prefectural Emergency and Critical Care Center, Imperial Gift Foundation Saiseikai, Utsunomiya Hospital, Japan.

Atsushi Hirayama (A)

Public Health, Department of Social Medicine, Graduate School of Medicine, Osaka University, Japan.

Hideo Yasunaga (H)

Department of Clinical Epidemiology and Health Economics, School of Public Health, the University of Tokyo, Japan.

Takashi Tagami (T)

Department of Emergency Medicine, Nippon Medical School Musashikosugi Hospital, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH